Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Tal R. Editorial Comment on 'Limited success with Clostridium Collagenase Histolyticum following FDA approval for the treatment of Peyronie's disease'. Int J Impot Res 2018;31:54-55. [PMID: 30333524 DOI: 10.1038/s41443-018-0086-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Accepted: 09/19/2018] [Indexed: 11/09/2022]

For:	Tal R. Editorial Comment on 'Limited success with Clostridium Collagenase Histolyticum following FDA approval for the treatment of Peyronie's disease'. Int J Impot Res 2018;31:54-55. [PMID: 30333524 DOI: 10.1038/s41443-018-0086-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Accepted: 09/19/2018] [Indexed: 11/09/2022]

Number	Cited by Other Article(s)
1	Collagenase Clostridium Histolyticum: A Review in Peyronie’s Disease. Clin Drug Investig 2019;40:83-92. [DOI: 10.1007/s40261-019-00867-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Collagenase Clostridium Histolyticum: A Review in Peyronie’s Disease. Clin Drug Investig 2019;40:83-92. [DOI: 10.1007/s40261-019-00867-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]